Initial public offerings scheduled to debut next week

NEW YORK — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of Jan. 6

I-Mab Biopharma – Shanghai, China, 7.4 million shares, priced $12-$15, managed by Jefferies/CICC. Proposed Nasdaq symbol IMAB. Business: Phase 3 biotech developing antibodies for cancer and autoimmune diseases.

The Associated Press